Release date
October 1, 2017

Annual review dates
October 1, 2018
October 1, 2019

Program expiration
October 1, 2020

Estimated time to complete activity: 6 hours

Mechanism for the learner to contact PIM – www.pimed.com

Jointly provided by Postgraduate Institute for Medicine and the Vascular Birthmarks Foundation.

This activity is supported by an independent educational grant from an anonymous individual donor. 

Target Audience

This activity is intended for physicians and related specialists engaged in the care of patients with vascular anamolies.

Educational Objectives

• Identify KTS and distinguish it from other vascular overgrowth syndromes
• Describe vascular anomalies present in KTS
• Explain the pathophysiology underlying the symptoms of KTS and their progression
• Locate published information about KTS
• Recognize the complications of KTS
• Choose appropriate treatment, including referral to a vascular anomalies center
• Identify the role of the interventionalist in treating vascular anomalies
• Differentiate the various types of vascular anomalies in order to choose the appropriate interventional treatment option
• Distinguish treatment options that include and exclude the role of the interventionalist
• Describe interventional treatment options for treating vascular anomalies
• Identify treatment and post-treatment obstacles
• Explore treatment modalities used by the interventionalist
• Distinguish complex cases treated with interventional strategies
• Compare and contrast treatment options
• Explore the critical value of accurate diagnosis for the best outcome for the interventionalist
• Describe issues interventionalists should discuss with patients
• Describe the application of various imaging modalities for the diagnosis of head and neck vascular anomalies
• Demonstrate impact of the imaging findings on critical features of various types hemangiomas, lymphatic malformations, venous malformations  and arteriovenous malformations or fistulas
• Explain the impact of imaging on treatment options
• Choose specific treatment options for each type of lesion based on the location and flow-dynamics of each individual vascular anomaly

Faculty

Learn more about our faculty.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Foundation for Vascular Anamolies. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Our faculty have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The Foundation for Vascular Anomalies  planners and managers have nothing to disclose.

Method of Participation and Request for Credit
The method of participation is through online courses, and upon passing quizzes with a 70% or better, a downloadable PDF will be available.

Computer System Requirements

Any computer, tablet or phone with a modern, up to date web browser can participate.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.